Neuroguard IEP
Device Cardiovascular
General payments
$23,674
Research payments
$3,861,324
Through program year 2024, $23,674 in general payments and $3,861,324 in research payments were reported against Neuroguard IEP (Cardiovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $450,465 | 108 |
| 2023 | Research | $674,253 | 128 |
| 2022 | General | $13,868 | 13 |
| 2022 | Research | $1,407,384 | 182 |
| 2021 | General | $9,590 | 28 |
| 2021 | Research | $1,329,221 | 142 |
| 2020 | General | $216 | 11 |
Breakdown
The top 5 of 8 recipients; each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2022 where a state was reported.
Records
52 general · 560 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.